recent news:Boehringer Ingelheim and Click Therapeutics to Develop and Commercialize a Digital Therapeutic for Schizophrenia in a $500M+ Collaboration Read more
Our Mission
Deliver safe and effective digital treatments to patients in need
We develop, validate, and commercialize software as prescription medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments.
Developing Software
As Treatments
We are a regulated Software as a Medical Device (SaMD)-focused biotechnology company that develops our applications as medical treatments in accordance with all relevant FDA, ISO and IEC standards.
01
Develop
Develop
We develop prescription software applications as medical devices that work independently or in conjunction with pharmacotherapies to treat disease.
02
Validate
Validate
We clinically validate these applications through rigorous randomized, controlled trials to demonstrate safety and efficacy.
03
Register
Register
We seek FDA clearance for our apps as class II medical devices with independent therapeutic treatment claims or as adjuncts to existing therapy.
04
Commercialize
Commercialize
Physicians prescribe our apps and payers reimburse for them, while we generate and apply real world evidence to continuously personalize and improve the applications.